☆ 3.8 Article

Presurgical avelumab plus axitinib in an immunosenescent octogenarian with renal cell carcinoma invading the vena cava

UROLOGY CASE REPORTS (2022)

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Immune Checkpoint Inhibitor Combination Therapy for Renal Cell Carcinomas With Concomitant Inferior Vena Cava Thrombi

Kazuhiko Yoshida et al.

Summary: This study evaluated the efficacy of immune checkpoint inhibitors in patients with renal cell carcinoma and inferior vena cava tumor thrombus. The results showed that all patients treated with immune checkpoint inhibitors had tumor shrinkage, and the level of the IVC thrombus was downstaged in some patients. Pre-surgical immune checkpoint inhibitor therapy had an impact on surgical strategy and reduced surgical risk.

IN VIVO (2022)

Add to Collection
Article Oncology

Efficacy of immune checkpoint inhibitors in elderly patients aged ≥ 75 years

Fausto Petrelli et al.

Summary: ICIs may offer a significant survival benefit in patients older than 75 years, especially in first-line trials.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Add to Collection
Article Oncology

Complete response of renal cell carcinoma with an inferior vena cava tumor thrombus and lung metastases after treatment with nivolumab plus ipilimumab

Tomoki Okada et al.

INTERNATIONAL CANCER CONFERENCE JOURNAL (2020)

Add to Collection
Article Oncology

Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy

Craig Labbate et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.